Micro Chemicals
Market Cap
₹1,529 ₹1,529 Cr.
P/E
14.81
PEG
2.06
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis becomes more credible if the Gelatin expansion and near-full Collagen Peptide capacity convert into recurring demand, with FY27 Collagen Peptide, DCP realization and export sales as key read-throughs.

The bull path requires faster Collagen Peptide demand and improved DCP realization, while the bear path is triggered by export weakness, raw-material inflation or disappointing conversion.

Margin performance will shape the earnings outcome as scale and cost controls offset lower Gelatin prices, freight pressure and competitive constraints.

Get your Reports on Demand
Get detailed, analyst-grade reports with actionable insights to make informed investment decisions.
  Flat 20% OFF
 for Tijori Premium Users
  Flat 20% OFF  for Tijori Premium Users
5Y Revenue & EBITDA Estimates
KEY TRIGGERS TO WATCH
  • The thesis becomes more credible if the Gelatin expansion and near-full Collagen Peptide capacity convert into recurring demand, with FY27 Collagen Peptide, DCP realization and export sales as key read-throughs.
  • The bull path requires faster Collagen Peptide demand and improved DCP realization, while the bear path is triggered by export weakness, raw-material inflation or disappointing conversion.
  • Margin performance will shape the earnings outcome as scale and cost controls offset lower Gelatin prices, freight pressure and competitive constraints.
Bear : 2.2% CAGR • ₹1,524 Cr
Base: 7.5% CAGR • ₹1,957 Cr
Bull: 11.1% CAGR • ₹2,307 Cr
Buy Report $5
Management Credibility Report
TRACK RECORD
  • 7 of 13 promises kept — but every miss clusters in one place : Solar, battery, and green-hydrogen timelines all slipped 18–24 months (H2 pushed ~7 years); the balance-sheet and 5G promises landed on time.
  • The tell : Management hits every target it controls (leverage 0.64x, EBITDA doubled to ₹2.08 lakh Cr, 5G on schedule) and misses every first-of-a-kind build-out — so haircut clean-energy dates by 18–24 months.
  • The number that doesn't add up : Revenue grew 5% but receivables jumped 26% and cash drained to ₹0.46 Cr — growth is turning cash-intensive right before the make-or-break renewal.
Met : 0
Progress: 0
Missed : 0
Buy Report $5
WORST-CASE SCENARIO
  • The balance sheet and cash generation provide a strong buffer, so the current risk profile is concentrated rather than systemic.
  • The most consequential vulnerability is dependence on the Nitta group distribution and customer relationship; a rupture could materially weaken the business and take years to replace.
  • Subsidiary liquidation, customs exposure and historical control and audit issues are important watchpoints, but appear financially manageable absent adverse escalation.
High Risk : 0
Medium Risk : 5
Low Risk : 12
Buy Report $5
Powered By
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material